Launch of $100 Million IPO
Cancer treatment company G1 Therapeutics (Pending:GTHX) has filed proposed terms for its $100 million IPO, aiming to sell 6.25 million shares of its common stock at a midpoint price of $16.00 per share.
Modified on August 10, 2017